CALLUNA PHARMA AS
CALLUNA PHARMA AS is registered as a limited company in Oslo, Oslo with organisation number 932255189. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023 and has 10 registered employees. Registered share capital is NOK 1.0m, divided into 104166995 shares. The company's stated purpose is: “Å investere i farmasøytiske selskaper og virksomheter, herunder å realisere slike investeringer, samt all annen virksomhet knyttet til dette.”.
Who owns CALLUNA PHARMA AS?
CALLUNA PHARMA AS has 7 registered shareholders:
- CALLUNA PHARMA POOLCO AS 34.9%
- FORBION VENTURES FUND VI COOPERATIV 24.1%
- FORCAL I INVESTMENT FUND 19.9%
- FORBION CAPITAL FUND IV COOPERATIEF 16.7%
- STITCHING ADMINISTRATIEKANTOOR OXIT 3.3%
- CALLUNA PHARMA POOLCO AS 0.7%
- CALLUNA PHARMA POOLCO AS 0.4%
Which companies does CALLUNA PHARMA AS own?
CALLUNA PHARMA AS holds a stake in 1 company:
- ARXX THERAPEUTICS AS 100.0%
Frequently asked questions about CALLUNA PHARMA AS
Who owns CALLUNA PHARMA AS?
CALLUNA PHARMA POOLCO AS is the largest registered owner, with 34.9%.
Who is the general manager of CALLUNA PHARMA AS?
Mark William-Semrau Gaffney is registered as general manager of CALLUNA PHARMA AS.
Where is CALLUNA PHARMA AS based?
CALLUNA PHARMA AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.